Coreline Soft is highlighting clinical results regarding the use of its AVIEW LCS for identifying and assessing pulmonary nodules in lung cancer screening.
A study published in the European Journal of Cancer on 27 December included data from the European lung cancer screening project, 4ITLR (4-IN-THE-LUNG-RUN), and demonstrated that AVIEW LCS showed a lower likelihood of misidentifying nodules larger than 100 mm³ compared with human radiologists, the company said.
The research reinforces "the foundation for AI technology to serve as a first reader during lung cancer screening processes," according to Coreline Soft.
